Hi-Tech Drugs Limited - Company Profile

It is a pharma public limited company based in Ratlam, Madhya Pradesh, India, established in 1988.
1988 Ratlam, Madhya Pradesh, India Active
Last Updated:
Access Report
About Hi-Tech Drugs Limited

Hi-Tech Drugs Limited, a active public limited company, was established on 25 August 1988 in Ratlam, Madhya Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239MP1988PLC004749. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹4.25 Cr and a paid-up capital of ₹4.10 Cr.

It upholds a compliant status. Its leadership includes Rajeev Kumar Jain (Director), Daluram Agrawal (Director), Sanjeev Kumar Jain (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at B-126 Deen Dayal Nagar, Ratlam, Madhya Pradesh, 457001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MP1988PLC004749

  • Registration Number

    004749

  • Incorporation Date

    25 August 1988

  • Authorized Capital

    ₹4.25 Cr

  • Paid-Up Capital

    ₹4.10 Cr

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.25 Cr
  • Paid Up Capital ₹ 4.10 Cr
  • Company Age 37 Year, 7 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth ****
  • Total Assets **** %
Company report

Hi-Tech Drugs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hi-Tech Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Hi-Tech Drugs Limited?
Current Directors
Name Designation Appointment Date Status
Rajeev Kumar Jain Director 25 Aug 1988 Current
Daluram Agrawal Director 06 Sep 1988 Current
Sanjeev Kumar Jain Director 25 Aug 1988 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hi-Tech Drugs.

Hi-Tech Drugs Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Hi-Tech Drugs revenue growth over time
Hi-Tech Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hi-Tech Drugs?

In 2021, Hi-Tech Drugs had a promoter holding of 46.30% and a public holding of 53.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Hi-Tech Drugs?

Unlock and access historical data on people associated with Hi-Tech Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hi-Tech Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hi-Tech Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hi-Tech Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Hi-Tech Drugs Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Hi-Tech Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Gwalior. was completed.

  • Director Appointment

    Daluram Agrawal was appointed as a Director was appointed as a Director on 06 Sep 1988 & has been associated with this company since 37 years 6 months . was recorded as a recent event.

  • Director Appointment

    The activity Rajeev Kumar Jain was appointed as a Director was appointed as a Director on 25 Aug 1988 & has been associated with this company since 37 years 7 months . was completed.

  • Director Appointment

    The activity Sanjeev Kumar Jain was appointed as a Director was appointed as a Director on 25 Aug 1988 & has been associated with this company since 37 years 7 months . was completed.

  • Company Incorporation

    Hi-Tech Drugs Limited was registered on 25 Aug 1988 with Roc Gwalior & aged 37 years 7 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hi-Tech Drugs Limited?

The CIN of Hi-Tech Drugs Limited is U24239MP1988PLC004749.

Where is Hi-Tech Drugs Limited headquartered?

Hi-Tech Drugs Limited is headquartered at B-126 Deen Dayal Nagar, Ratlam, Madhya Pradesh, 457001.

When was Hi-Tech Drugs Limited incorporated?

Hi-Tech Drugs Limited was incorporated on 25 August 1988.

Who are the current directors of Hi-Tech Drugs Limited?

The current directors of Hi-Tech Drugs Limited are

What is the primary industry of Hi-Tech Drugs Limited?

The primary industry of Hi-Tech Drugs Limited is Pharma.

Is Hi-Tech Drugs Limited a listed company?

Hi-Tech Drugs Limited is unlisted.

What is the capital structure of Hi-Tech Drugs Limited?

The authorized capital of Hi-Tech Drugs Limited is ₹4.25 Cr, and the paid-up capital is ₹4.10 Cr.

What is the compliance status of Hi-Tech Drugs Limited?

The compliance status of Hi-Tech Drugs Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available